Arene oxides epoxidation

In some cases. Phase I metabolites may not be detected, owing to their instability or high chemical reactivity. The latter type are often electrophilic substances, called reactive intermediates, which frequently react non-enzymically as well as enzymically with conjugating nucleophiles to produce a Phase II metabolite. A common example of this type is the oxidative biotransformation of an aromatic ring and conjugation of the resulting arene oxide (epoxide) with the tripeptide glutathione. Detection of metabolites derived from this pathway often points to the formation of precursor reactive electrophilic Phase I metabolites, whose existence is nonetheless only inferred. 

Traditionally, the hydroxylation of aromatic compounds by CYP450 has been considered to be mediated by an arene oxide (epoxide) intermediate followed by the NIH shift," as discussed previously (29,30,31) (Fig. 10.6). The formation of phenols and fhe isolation of urinary dihydrodiols, catechols, and glutathione conjugates (mercapturic acid derivatives) implicates arene oxides as intermediates in the metabolism of benzene and substituted benzenes in mammalian systems. The arene oxides... 

Figure 7.9 Another environmental carcinogen is benzo[a]pyrene (BaP). One site of metabolic attack is the terminal ring which is oxidized to form a 7,8-arene oxide. Epoxide hydrolase opens this to form a frans-7,8-dihydrodiol.The remaining C=C bond in the ring may also undergo oxidation to form an epoxide, with the oxidation directed to the same face as the allylic alcohol by coordination of the metabolizing enzyme. This epoxide is now on the opposite face as the benzylic hydroxyl group and is named BaP-frans-7,8-diol-anf/-9,10-epoxide.This is especially stable because it is adjacent to the sheltered bay region of the molecule. It can be opened by epoxide hydrolase to form a detoxified tetraol. Alternatively, DNA can open the epoxide to form a covalent adduct that is responsible for tumor initiation.

The process of biocatalytic dihydroxylation, the conversion of a carton-carbon double bond to a saturated vicinal diol, is summarized in Fig, 2. This reaction, when carried out on an aromatic substrate, may be catalyzed by a monooxygenase enzyme and proceed via an arene oxide (epoxide) intermediate to give a franr-diol, but is exclusively the domain... 

Although details vary for particular cases, a common synthetic route to diol epoxides such as (30) frequently begins with the ketone (33) (78MI50700). The final epoxidation is often highly stereoselective. A general route to non-K-region arene oxides has been described (75JA3185). 

Diol epoxides. Structural considerations. Because enzymatic hydration of arene oxides produces trans dihydrodiols in mammalian cells, there are two diastereomeric series of diol epoxides. In... 

Arene oxides and diol epoxides are generally unstable in aqueous, especially acidic media (103-105). and in addition, several groups have noted that DNA has a marked catalytic effect upon diol epoxide hydrolysis (106.107). However, in cells there appears to be sites, probably lipid in nature, in which these compounds can have much longer half-lives. 

Hydrolysis of epoxides and arene oxides Hydrolysis of amides and esters Hydrolysis of glycosides... 

As with an isolated double bond, epoxide formation in an aromatic ring, i.e., arene oxide formation, can occur mechanistically either by a concerted addition of oxene to form the arene oxide in a single step, pathway 1, or by a stepwise process, pathway 2 (Fig. 4.78). The stepwise process, pathway 2, would involve the initial addition of enzyme-bound Fe03+ to a specific carbon to form a tetrahedral intermediate, electron transfer from the aryl group to heme to form a carbonium ion adjacent to the oxygen adduct followed by... 

It is sometimes assumed that every phenol metabolite indicates the formation of an arene oxide intermediate however, as discussed above, arene oxides are not obligate intermediates in the formation of phenols. This is an important distinction because arene oxides and other epoxides are reactive intermediates that can be toxic or even carcinogenic, e.g., epoxides of some polycyclic aromatic hydrocarbons. The question of whether their formation is obligatory is significant for drug design and development and has implications for toxicity as discussed in Chapter 8. 

Epoxides/arene oxides have varying degrees of chemical reactivity and can be detoxified by hydrolysis to dihydrodiols as shown in Figure 6.8. This can occur either nonenzy-matically, if the epoxide is very reactive, or it can be catalyzed enzymatically by epoxide hydrolase (EH). 

In contrast, the primary role of microsomal EH appears to be in detoxifying the metabolically produced epoxides of drugs, e.g., carbamazepine epoxide, the arene oxide of diphenylhydantoin, and the epoxides of environmental contaminants like the polycyclic aromatic hydrocarbons, e.g., benzo[a]pyrene. 

The observation of a dihydrodiol has been taken as proof that an epoxide (arene oxide) is the precursor metabolite. Many epoxides, such as the 10,11-epoxide of carbamazepine shown above and even the arene oxide of benzene, which is quite reactive, have been directly observed. Others such as the epoxide of phenytoin are only inferred. It is conceivable that some dihydrodiols are formed by reaction of an intermediate with water in the active site of P450 without the formation of an epoxide. One clue to the origin of the dihydrodiol is the stereochemistry an exclusively tram-dihydrodiol suggests that it was formed via the EH-mediated hydrolysis of an epoxide or arene oxide. 

Alkenes may be oxidized to epoxides that are reactive metabolites because of ring strain [36] and can undergo nucleophilic attack. Epoxides are not always highly reactive species. In fact, some of them are relatively unreactive for example, the arene oxides that derive from oxidation of phenyl rings. Most drugs containing a phenyl... 

The publication (70) in 1976 of the preparation of optically active epoxyketones via asymmetric catalysis marked the start of an increasingly popular field of study. When chalcones were treated with 30% hydrogen peroxide under (basic) phase-transfer conditions and the benzylammonium salt of quinine was used as the phase-transfer catalyst, the epoxyketones were produced with e.e. s up to 55%. Up to that time no optically active chalcone epoxides were known, while the importance of epoxides (arene oxides) in metabolic processes had just been discovered (71). The nonasymmetric reaction itself, known as the Weitz-Scheffer reaction under homogeneous conditions, has been reviewed by Berti (70). 

Conversion of epoxides (arene oxides) into phenols is spontaneous. The conversion of epoxides into dihydrodiols is catalyzed by EH (EC 4.2.1.63). Hydroxyl containing PAHs can act as substrates for conjugases (C) (UDP glucuronsyl transferase (EC 2.4.1.17) and phenol sulphotransferase (EC 2.8.2.1)). This pathway usually leads to inactive excretable products. Epoxides are scavenged by GSH and the reaction is catalyzed by GSHt (EC 2.5.1.18). When GSH is depleted and/or the other pathways are saturated, epoxides of dihydrodiols (particularly 7,8-diol-9,10-epoxides in the case of BP) and phenol metabolites react with cellular macromolecules such as DNA, RNA, and protein. If repair mechanisms are exceeded the detrimental effects of PAH may result. 

Jerina, D. M., Dansette, P. M., Lu, A. Y. H., and Levin, W. Hepatic microsomal epoxide hydrase a sensitive radiometric assay for hydration of arene oxides of carcinogenic aromatic hydrocarbons. Mol. Pharmacol. (1977) 13 342-351. 

This chapter begins, thus, with a short introduction to the chemical reactivity of epoxides. We continue with a description of the epoxides hydrolases and their biochemistry, and devote most of its length to a systematic discussion of the substrates hydrated by these enzymes. Arene oxides and diol epoxides will be presented first, followed by a large variety of alkene and cy-cloalkene oxides. 

In rearrangement reactions that lead to isomerization, an important discrimination must be made between epoxides of aromatic compounds, e.g., benzene oxide (10.1, Fig. 10.1), and epoxides of alkenes. As a class, epoxides of aromatic compounds (also known as arene oxides) are markedly un-... 

Another isomerization reaction of arene oxides is equilibrium with oxe-pins [5], Here, the fused six-membered carbocycle and three-membered oxirane merge to form a seven-membered heterocycle, as shown in Fig. 10.2. An extensive computational and experimental study involving 75 epoxides of monocyclic, bicyclic, and polycyclic aromatic hydrocarbons has revealed much information on the structural factors that influence the reaction rate and position of equilibrium [11], Thus, some compounds were stable as oxepins (e.g., naphthalene 2,3-oxide), while others exhibited a balanced equilibrium... 

In contrast, a number of alkene epoxides (10.3) are chemically quite stable, i.e., intrinsically less reactive than arene oxides. Examples of epoxide metabolites that have proven to be stable enough to be isolated in the absence of degrading enzymes include 1,2-epoxyoctane (10.4), 1,2-epoxycyclohex-ane (10.5), 1-phenyl-1,2-epoxy ethane (styrene oxide, 10.6), and cis- 1,2-diphenyl-1,2-epoxyethane (cfv-stilbene oxide, 10.7) [12], The same is true of alclofenac epoxide (10.8), hexobarbital epoxide (10.9), and a few other epoxides of bioactive compounds. 

The microsomal epoxide hydrolases (microsomal EH, mEH), predominantly found in the endoplasmic reticulum, regio- and stereoselectively catalyze the hydration of both alkene and arene oxides, including oxides of polycyclic aromatic hydrocarbons. These enzymes have been purified to homogeneity from various species and tissues [22] [41 - 46], The human microsomal EH contains 455 amino acids (Mr 52.5 kDa) and is the product of the EPHX1 gene [47] (also known as HYL1 [48]). 

The overall reaction catalyzed by epoxide hydrolases is the addition of a H20 molecule to an epoxide. Alkene oxides, thus, yield diols (Fig. 10.5), whereas arene oxides yield dihydrodiols (cf. Fig. 10.8). In earlier studies, it had been postulated that epoxide hydrolases act by enhancing the nucleo-philicity of a H20 molecule and directing it to attack an epoxide, as pictured in Fig. 10.5, a [59] [60], Further evidence such as the lack of incorporation of 180 from H2180 into the substrate, the isolation of an ester intermediate, and the effects of group-selective reagents and carefully designed inhibitors led to a more-elaborate model [59][61 - 67]. As pictured in Fig. 10.5,b, nucleophilic attack of the substrate is mediated by a carboxylate group in the catalytic site to form an ester intermediate. In a second step, an activated H20... 

Together with glutathione conjugation, hydration is a major pathway in the inactivation and detoxification of arene oxides. Exceptions to this rule will be treated when discussing polycyclic aromatic hydrocarbons. Arene oxides are good substrates for microsomal EH, as evidenced in Table 10.1, where hydration of selected arene oxides, alkene oxides, and cy-cloalkene oxides by purified rat liver epoxide hydrolase is compared. The hy- ... 

Detailed kinetic studies comparing the chemical reactivity ofK-region vs. non-K-region arene oxides have yielded important information. In aqueous solution, the non-K-region epoxides of phenanthrene (the 1,2-oxide and 3,4-oxides) yielded exclusively phenols (the 1-phenol and 4-phenol, respectively, as major products) in an acid-catalyzed reaction, as do epoxides of lower arenes (Fig. 10.1). In contrast, the K-region epoxide (i.e., phenanthrene 9,10-oxide 10.29) gave at pH < 7 the 9-phenol and the 9,10-dihydro-9,10-diol (predominantly trans) in a ratio of ca. 3 1. Under these conditions, the formation of this dihydrodiol was found to result from trapping of the carbonium ion by H20 (Fig. 10.11, Pathway a). At pH > 9, the product formed was nearly ex-... 

In other words, the non-K-region epoxides of phenanthrene react like epoxides of lower arenes (Fig. 10.1). In contrast, the K-region epoxide of phenanthrene, under alkaline conditions, hydrolyzes as does an olefin epoxide (i.e., as in Fig. 10.4), but seemingly faster. Under acidic conditions, however, it exhibits dual behavior, isomerizing mainly like an arene oxide (i.e.,... 

As explained in the Introduction, alkene oxides (10.3) are generally chemically quite stable, indicating reduced reactivity compared to arene oxides. Under physiologically relevant conditions, they have little capacity to undergo rearrangement reactions, one exception being the acid-catalyzed 1,2-shift of a proton observed in some olefin epoxides (see Sect. 10.2.1 and Fig. 10.3). Alkene oxides are also resistant to uncatalyzed hydration, thus, in the absence of hydrolases enzymes, many alkene oxides that are formed as metabolites are stable enough to be isolated. 

The data in Table 10.1 suggest that the reactivity of epoxide hydrolase toward alkene oxides is highly variable and appears to depend, among other things, on the size of the substrate (compare epoxybutane to epoxyoctane), steric features (compare epoxyoctane to cycloalkene oxides), and electronic factors (see the chlorinated epoxides). In fact, comprehensive structure-metabolism relationships have not been reported for substrates of EH, in contrast to some narrow relationships that are valid for closely related series of substrates. A group of arene oxides, along with two alkene oxides to be discussed below (epoxyoctane and styrene oxide), are compared as substrates of human liver EH in Table 10.2 [119]. Clearly, the two alkene oxides are among the better substrates for the human enzyme, as they are for the rat enzyme (Table 10.1). 

---